Chemours Co
$ 23.32
0.60%
20 Apr - close price
- Market Cap 3,479,579,000 USD
- Current Price $ 23.32
- High / Low $ 23.54 / 22.96
- Stock P/E N/A
- Book Value 1.67
- EPS -2.57
- Next Earning Report 2026-05-05
- Dividend Per Share $0.51
- Dividend Yield 2.15 %
- Next Dividend Date -
- ROA 0.02 %
- ROE -0.94 %
- 52 Week High 24.13
- 52 Week Low 8.97
About
The Chemours Company offers high performance chemicals in North America, Asia Pacific, Europe, the Middle East, Africa and Latin America. The company is headquartered in Wilmington, Delaware.
Analyst Target Price
$21.67
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-02-05 | 2025-11-04 | 2025-08-05 | 2025-05-06 | 2025-02-18 | 2024-11-04 | 2024-08-01 | 2024-04-30 | 2024-03-27 | 2023-10-26 | 2023-07-27 | 2023-04-27 |
| Reported EPS | 0.05 | 0.2 | 0.58 | 0.13 | 0.11 | 0.4 | 0.38 | 0.32 | 0.31 | 0.63 | 1.1 | 0.98 |
| Estimated EPS | 0.0774 | 0.24 | 0.46 | 0.2 | 0.16 | 0.28 | 0.57 | 0.18 | 0.25 | 0.69 | 1.07 | 0.47 |
| Surprise | -0.0274 | -0.04 | 0.12 | -0.07 | -0.05 | 0.12 | -0.19 | 0.14 | 0.06 | -0.06 | 0.03 | 0.51 |
| Surprise Percentage | -35.4005% | -16.6667% | 26.087% | -35% | -31.25% | 42.8571% | -33.3333% | 77.7778% | 24% | -8.6957% | 2.8037% | 108.5106% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-05 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | -0.05 |
| Currency | USD |
Previous Dividend Records
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2026-03-13 | 2025-12-15 | 2025-09-12 | 2025-06-16 | 2025-03-14 | 2024-12-16 | 2024-09-13 | 2024-06-14 | 2024-03-15 | 2023-12-15 |
| Amount | $0.0875 | $0.0875 | $0.0875 | $0.0875 | $0.25 | $0.25 | $0.25 | $0.25 | $0.25 | $0.25 |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: CC
2026-04-20 17:39:13
The article provides a financial overview for Chemours Co. (SWB:2CU), listed on the Stuttgart Stock Exchange, focusing on its net current asset value per share. It is presented within the TradingView platform, offering various market data and analysis tools for investors. The content appears to be a stub or a section focused solely on this financial metric.
2026-04-18 08:39:15
The Chemours Company (NYSE:CC) has received an average recommendation of "Hold" from brokerages, with several analysts recently updating their price targets. While the company exceeded quarterly EPS estimates, its revenue was slightly down year-over-year, and it carries a negative net margin despite a high return on equity. Institutional investors hold a significant portion of Chemours' stock.
2026-04-18 04:39:15
The Chemours Co. reached a new 52-week high of $24.12, a significant increase from its low of $9.13, despite a 0.25% decline in its one-year performance compared to the S&P 500's 33.47% gain. The company, a small-cap stock with a market capitalization of $3,138 million, is currently loss-making despite its recent stock price surge. It has a dividend yield of 1.67% and a debt-to-equity ratio of 13.88.
2026-04-17 15:10:35
Chemours' Fayetteville Works has achieved Gold-level WHC Conservation Certification for its commitment to environmental stewardship, biodiversity, and community engagement. This recognition, awarded through a third-party evaluation, highlights the site's comprehensive approach to habitat management, wildlife conservation, and education programs. The initiative involves extensive forest habitat stewardship, various wildlife and pollinator programs, and strong partnerships with local schools and community organizations.
2026-04-16 22:09:00
The Chemours Co (CC) saw its shares rise 3.6% to $23.87, but GuruFocus's GF Value indicates the stock is 14.7% overvalued compared to its estimated intrinsic value of $20.81. Despite a strong momentum score of 9/10, the company's financial strength is rated low at 3/10, suggesting potential vulnerabilities. Investors are advised to exercise caution due to the overvaluation and the stock's forward P/E ratio of 16.8x being above its 5-year median.
2026-04-14 09:08:47
Chemours (NYSE:CC) recently hit a new 52-week high of $23.20, trading on strong volume and well above its moving averages. While analyst sentiment is mixed with an average "Hold" rating and $20.40 price target, UBS recently raised its target to $29 and reiterated a "Buy." The company's fundamentals currently show mixed results, including beating EPS expectations but having negative net margin and P/E, alongside a 1.5% dividend yield.
